These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25830197)

  • 21. Is the FDA on drugs?
    Calabresi M; Park A
    Time; 2010 Aug; 176(8):24-8. PubMed ID: 20821962
    [No Abstract]   [Full Text] [Related]  

  • 22. Removal of regulations regarding certification of drugs composed wholly or partly of insulin--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(92):26694-9. PubMed ID: 10179341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDA raises concerns about ultra-long acting insulins given green light in Europe and Japan.
    Torjesen I
    BMJ; 2012 Oct; 345():e7323. PubMed ID: 23112064
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA approves new inhaler without CFCs.
    FDA Consum; 2001; 35(4):3. PubMed ID: 11692883
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiovascular safety and diabetes drug development.
    Drucker DJ; Goldfine AB
    Lancet; 2011 Mar; 377(9770):977-9. PubMed ID: 21316097
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA places greater restrictions on access to rosiglitazone.
    BMJ; 2010 Sep; 341():c5287. PubMed ID: 20870699
    [No Abstract]   [Full Text] [Related]  

  • 27. The critical path from pump to pancreas: the impact of FDA regulation on the development of a closed-loop diabetes management system.
    Sanchez RM
    Food Drug Law J; 2013; 68(1):53-76, i. PubMed ID: 24640637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PROMAXX inhaled insulin: safe and efficacious administration with a commercially available dry powder inhaler.
    Heise T; Brugger A; Cook C; Eckers U; Hutchcraft A; Nosek L; Rave K; Troeger J; Valaitis P; White S; Heinemann L
    Diabetes Obes Metab; 2009 May; 11(5):455-9. PubMed ID: 19236443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant FDA approvals in 1999.
    McGinnis TJ
    Am Fam Physician; 2000 Apr; 61(8):2531-3. PubMed ID: 10794586
    [No Abstract]   [Full Text] [Related]  

  • 30. FDA committees say keep rosiglitazone available but increase warnings.
    Tanne JH
    BMJ; 2007 Aug; 335(7613):223. PubMed ID: 17673743
    [No Abstract]   [Full Text] [Related]  

  • 31. Afrezza: some questions about a new approach to prandial insulin.
    Bloomgarden ZT
    J Diabetes; 2014 Nov; 6(6):489-90. PubMed ID: 25209874
    [No Abstract]   [Full Text] [Related]  

  • 32. Beyond insulin: what else might help?
    Scheiner G
    Diabetes Self Manag; 2014; 31(1):30, 32-4. PubMed ID: 24640060
    [No Abstract]   [Full Text] [Related]  

  • 33. The rosiglitazone story--lessons from an FDA Advisory Committee meeting.
    Rosen CJ
    N Engl J Med; 2007 Aug; 357(9):844-6. PubMed ID: 17687124
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of hyperkalemia in dialysis patients.
    Putcha N; Allon M
    Semin Dial; 2007; 20(5):431-9. PubMed ID: 17897250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major US consumer group asks FDA to ban drug for diabetes.
    Tanne JH
    BMJ; 2008 Nov; 337():a2401. PubMed ID: 18987042
    [No Abstract]   [Full Text] [Related]  

  • 36. Nuclear medicine wins decision in FDA PET case.
    Nichols D
    J Nucl Med; 1997 Dec; 38(12):23N. PubMed ID: 9430453
    [No Abstract]   [Full Text] [Related]  

  • 37. [Application for marketing authorization accepted for the the treatment of adult diabetes].
    Solignac M
    Soins; 2013 Jun; (776):8. PubMed ID: 23878876
    [No Abstract]   [Full Text] [Related]  

  • 38. US FDA approves three new drugs for Type 2 diabetes.
    Bond T
    Expert Rev Clin Pharmacol; 2013 Mar; 6(2):101. PubMed ID: 23593719
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA committee urges tight restrictions on rosiglitazone.
    Roehr B
    BMJ; 2010 Jul; 341():c3862. PubMed ID: 20639290
    [No Abstract]   [Full Text] [Related]  

  • 40. What went wrong? A retrospective on Exubera.
    Baran MK; Godoy AT
    Adv Nurse Pract; 2008 Nov; 16(11):53-4, 77. PubMed ID: 19999057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.